IDNNA

IDNNA
Clinical data
Other names4-Iodo-2,5-dimethoxy-N,N-dimethylamphetamine; 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine; N,N-Dimethyl-DOI
Routes of
administration		Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 1-(4-iodo-2,5-dimethoxyphenyl)-N,N-dimethylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H20INO2
Molar mass349.212 g·mol−1
3D model (JSmol)
  • Ic1cc(OC)c(cc1OC)CC(N(C)C)C
  • InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Y
  • Key:XBCUSBRGRALQID-UHFFFAOYSA-N Y
  (verify)

IDNNA, also known as 4-iodo-2,5-dimethoxy-N,N-dimethylamphetamine or as N,N-dimethyl-DOI, is a lesser-known psychoactive drug and a substituted amphetamine.[1] It is also the N,N-dimethyl analogue of DOI.[1]

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), the minimum dose is listed as 2.6 mg and the duration as unknown.[1] IDNNA produces few to no effects.[1]

Society and culture

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

  1. ^ a b c d e f IDNNA Entry in PiHKAL
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.